Vimarsana
Biggest News Aggregation in the World

Page 2 - Greg Berk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Berk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Berk Today - Breaking & Trending Today

GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer - Vimarsana News

GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer

GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the

GT Biopharma Names Dr. Jeff Miller as Consulting Chief - Vimarsana News

GT Biopharma Names Dr. Jeff Miller as Consulting Chief

BRISBANE, CALIFORNIA, Dec. 14, 2022 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage immuno-oncology...

'A tremendous leader': Firefighters pay tribute to former Wheaton, Flossmoor chief - Vimarsana News

'A tremendous leader': Firefighters pay tribute to former Wheaton, Flossmoor chief

Former Wheaton Fire Chief Berk inspired generations of firefighters over a career spanning 46 years. "He was always a mentor to me," said Bill Schultz, Berk's successor. Firefighters gave a final salute to Berk at his funeral earlier this week.

GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022 - Vimarsana News

GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022

GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022 - read this article along with other careers information, tips and advice on BioSpace

GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022 - Vimarsana News

GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022

/PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...